Recently, several reports have suggested that salicylazosulfapyridine causes a reduction in
semen quality in patients with ulcerative colitis. After withdrawal of the drug pregnancies …

The semen qualities of six patients with salicylazosulfapyridine-treated chronic ulcerative
colitis are discussed. Over-all poor parameters were observed during the treatment period …

Salicylazosulfapyridine (SASP), a drug used in the treatment of inflammatory bowel
diseases, has been reported to depress the fertility in males. Therefore, some authors have …

Our purpose was to study the effects of long‐term salazopyrine treatment on male fertility.
Seven patients, 21–37 years old, who had been treated for ulcerative colitis with 3 g/day of …

Some semen characteristics of eight male patients with clinically inactive ulcerative colitis
were investigated. Semen analysis was carried out twice during sali-cylazosulfapyridine …

Male infertility is widlely accepted as a common complication of sulphasalazine (SASP)
therapy for inflammatory bowel disease. SASP is used in the maintenance long-term …

A male patient suffering from ulcerative colitis, presented with primary infertility due to
sulphasalazine therapy. Sulphasalazine was discontinued and the patient was treated with …

Seminal abnormalities are commonly found during sulphasalazine treatment. Although
these changes appear reversible after drug withdrawal this may result in colitis relapse …

The fertility of men with inflammatory bowel disease (IBD) has not been studied
prospectively in much detail. It seems to be normal in the vast majority of cases; however, it …

Seminal abnormalities are a common side effect of Salazosulphapyridine (SASP) treatment.
We evaluated semen qualities and sex hormone concentrations in 11 patients with …